The impact of neonatal 17-hydroxyprogesterone cutoff determination in a public newborn screening program for congenital adrenal hyperplasia in Southern Brazil: 3 years’ experience
Congenital adrenal hyperplasia (CAH) occurs due to enzyme defects in adrenal steroidogenesis. The 21-hydroxylase deficiency accounts for 90–95% of cases, triggering accumulation of 17-hydroxyprogesterone (17-OHP). Early diagnosis through neonatal screening allows adequate treatment and reduced morta...
Egile Nagusiak: | , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Bioscientifica
2023-10-01
|
Saila: | Endocrine Connections |
Gaiak: | |
Sarrera elektronikoa: | https://ec.bioscientifica.com/view/journals/ec/aop/ec-23-0162/ec-23-0162.xml |